NCT00914160

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions

A Relative Bioavailability Study of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Sandoz · Industry
• Sex: Male
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

To demonstrate the relative bioavailability of Diclofenac Sodium 50 mg enteric-coated tablets under non-fasting conditions.

Conditions

• Inflammation

Interventions

Type	Name	Description
DRUG	Diclofenac Sodium 50 mg Tablets Under Fasting Conditions (Geneva Pharmaceuticals, Inc)
DRUG	Diclofenac Sodium 50 mg Tablets Under Fed Conditions (Geneva Pharmaceuticals, Inc)
DRUG	Voltaren 50 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals)

Timeline

• Start date: 1993-08-01
• Primary completion: 1993-09-01
• Completion: 1993-09-01
• First posted: 2009-06-04
• Last updated: 2017-03-28